Top ▲
target has curated data in GtoImmuPdb
Target id: 1875
Nomenclature: Fas
Systematic Nomenclature: TNFRSF6
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 335 | 10q23.31 | FAS | Fas cell surface death receptor | |
Mouse | 1 | 327 | 19 29.48 cM | Fas | Fas cell surface death receptor | |
Rat | 1 | 324 | 1q52 | Fas | Fas cell surface death receptor |
Database Links ![]() |
|
Alphafold | P25445 (Hs), P25446 (Mm), Q63199 (Rn) |
ChEMBL Target | CHEMBL4523207 (Hs), CHEMBL2417350 (Rn) |
Ensembl Gene | ENSG00000026103 (Hs), ENSMUSG00000024778 (Mm), ENSRNOG00000019142 (Rn) |
Entrez Gene | 355 (Hs), 14102 (Mm), 246097 (Rn) |
Human Protein Atlas | ENSG00000026103 (Hs) |
KEGG Gene | hsa:355 (Hs), mmu:14102 (Mm), rno:246097 (Rn) |
OMIM | 134637 (Hs) |
Pharos | P25445 (Hs) |
UniProtKB | P25445 (Hs), P25446 (Mm), Q63199 (Rn) |
Wikipedia | FAS (Hs) |
Natural/Endogenous Ligands ![]() |
Fas ligand {Sp: Human} |
Adaptor proteins (Human) |
FADD |
Immunopharmacology Comments |
Fas receptor (CD95) is a cell surface protein that belongs to the tumor necrosis factor receptor family, that along with its ligand CD95L, generates a death receptor/death ligand system that mediates apoptosis induction to maintain immune homeostasis. This system is also important in the immune elimination of virus-infected cells, cancer cells and autoreactive T cells. Mouse strains with mutations in Fas or CD95L develop lymphoproliferative conditions, indicating the importance of these proteins to immune cell homeostasis [2]. The phenotype of Fas-mutant mice presents in a systemic lupus erythematosus-like autoimmune disease [3]. Fas or CD95L knockout mice show a more severe autoimmune phenotype than the mutant mice mentioned. Humans with type 1a and 1b autoimmune lymphoproliferative syndrome (ALPS) carry mutations in Fas and CD95L respectively. |
Immuno Process Associations | |||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
Immuno Disease Associations | ||||||||||
|
Phenotypes, Alleles and Disease Models ![]() |
Mouse data from MGI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Clinically-Relevant Mutations and Pathophysiology ![]() |
||||||||||||||
|
1. Bidère N, Su HC, Lenardo MJ. (2006) Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol, 24: 321-52. [PMID:16551252]
2. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76 (6): 969-76. [PMID:7511063]
3. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356 (6367): 314-7. [PMID:1372394]